SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-23-219474
Filing Date
2023-08-24
Accepted
2023-08-24 06:15:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFC14A d447529ddefc14a.htm DEFC14A 718160
2 GRAPHIC g447529g05g07.jpg GRAPHIC 85245
3 GRAPHIC g447529g05g08.jpg GRAPHIC 83929
4 GRAPHIC g447529g19n78.jpg GRAPHIC 18085
5 GRAPHIC g447529g26k02.jpg GRAPHIC 30243
6 GRAPHIC g447529page062.jpg GRAPHIC 7505
  Complete submission text file 0001193125-23-219474.txt   1027488
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filed by) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-38052 | Film No.: 231198863
SIC: 2834 Pharmaceutical Preparations